BG104963A - Многочастична фармацевтична форма със забавено и пулсационно освобождаване и метод за получаването й - Google Patents

Многочастична фармацевтична форма със забавено и пулсационно освобождаване и метод за получаването й

Info

Publication number
BG104963A
BG104963A BG104963A BG10496300A BG104963A BG 104963 A BG104963 A BG 104963A BG 104963 A BG104963 A BG 104963A BG 10496300 A BG10496300 A BG 10496300A BG 104963 A BG104963 A BG 104963A
Authority
BG
Bulgaria
Prior art keywords
pharmaceutical form
active principle
timed release
polymer
hours
Prior art date
Application number
BG104963A
Other languages
English (en)
Other versions
BG64764B1 (bg
Inventor
Edouard Gendrot
Gerard Cousin
Francoise Ragot
Marie-Christine Clee-Bouvet
Original Assignee
Ethypharm S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm S.A. filed Critical Ethypharm S.A.
Publication of BG104963A publication Critical patent/BG104963A/bg
Publication of BG64764B1 publication Critical patent/BG64764B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Фармацевтичната форма започва да освобождава активната съставна част от 4 до 8 h след поглъщане, след което постепенно се освобождава основната съставна част през следващите от 8 до 20 h. Тази формане съдържа органична киселина и представлява лекарствени сфероиди. Те се състоят от неутрална сферична основа с първо покритие на базата на смес от поне един водонеразтворим полимер, в който равномерно са разположени съставящите частици на активнатасъставна част. Цялата активна част има второ покритие на основата на поне два рН-независими полимера, които са с различни степени на пропускливост по отношение различните стомашни и чревни среди, в даден случай поне един рН-независим полимер, поне един пластификатор и поне един инертен (неактивен)пълнеж, равномерно разпределен в покритието.
BG104963A 1998-05-20 2000-11-17 Многочастична фармацевтична форма със забавено и пулсационно освобождаване и метод за получаването й BG64764B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9806384A FR2778848B1 (fr) 1998-05-20 1998-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation

Publications (2)

Publication Number Publication Date
BG104963A true BG104963A (bg) 2001-07-31
BG64764B1 BG64764B1 (bg) 2006-03-31

Family

ID=9526556

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104963A BG64764B1 (bg) 1998-05-20 2000-11-17 Многочастична фармацевтична форма със забавено и пулсационно освобождаване и метод за получаването й

Country Status (25)

Country Link
EP (1) EP1077687B1 (bg)
JP (1) JP2002515423A (bg)
KR (1) KR100583065B1 (bg)
CN (1) CN1186014C (bg)
AT (1) ATE214598T1 (bg)
AU (1) AU758299B2 (bg)
BG (1) BG64764B1 (bg)
BR (1) BR9910606A (bg)
CA (1) CA2333188C (bg)
DE (1) DE69901062T2 (bg)
DK (1) DK1077687T3 (bg)
ES (1) ES2173739T3 (bg)
FR (1) FR2778848B1 (bg)
GE (1) GEP20022750B (bg)
HK (1) HK1033271A1 (bg)
HU (1) HU224193B1 (bg)
IL (1) IL139774A (bg)
MX (1) MXPA00011364A (bg)
NO (1) NO330501B1 (bg)
NZ (1) NZ508392A (bg)
PL (1) PL192950B1 (bg)
PT (1) PT1077687E (bg)
TR (1) TR200100107T2 (bg)
WO (1) WO1999059557A1 (bg)
ZA (1) ZA200006768B (bg)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
CA2529984C (en) 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ709754A (en) 2004-10-21 2017-02-24 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
AU2013273835B2 (en) * 2005-05-02 2016-07-07 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US9161918B2 (en) * 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle

Also Published As

Publication number Publication date
NO20005838L (no) 2001-01-10
AU3830299A (en) 1999-12-06
NZ508392A (en) 2002-09-27
PL192950B1 (pl) 2006-12-29
FR2778848B1 (fr) 2001-11-23
IL139774A (en) 2005-09-25
AU758299B2 (en) 2003-03-20
WO1999059557A1 (fr) 1999-11-25
CA2333188A1 (fr) 1999-11-25
IL139774A0 (en) 2002-02-10
FR2778848A1 (fr) 1999-11-26
DK1077687T3 (da) 2002-06-17
MXPA00011364A (es) 2008-09-09
NO20005838D0 (no) 2000-11-17
HUP0102027A2 (hu) 2002-03-28
KR100583065B1 (ko) 2006-06-08
ATE214598T1 (de) 2002-04-15
BG64764B1 (bg) 2006-03-31
CN1186014C (zh) 2005-01-26
CN1305371A (zh) 2001-07-25
PL344314A1 (en) 2001-10-22
CA2333188C (fr) 2010-07-06
JP2002515423A (ja) 2002-05-28
HK1033271A1 (en) 2001-08-24
ZA200006768B (en) 2001-11-20
DE69901062D1 (de) 2002-04-25
NO330501B1 (no) 2011-05-02
DE69901062T2 (de) 2002-10-31
HU224193B1 (hu) 2005-06-28
BR9910606A (pt) 2001-10-02
GEP20022750B (en) 2002-08-26
HUP0102027A3 (en) 2002-12-28
EP1077687A1 (fr) 2001-02-28
EP1077687B1 (fr) 2002-03-20
TR200100107T2 (tr) 2001-06-21
ES2173739T3 (es) 2002-10-16
KR20010052370A (ko) 2001-06-25
PT1077687E (pt) 2002-09-30

Similar Documents

Publication Publication Date Title
BG104963A (bg) Многочастична фармацевтична форма със забавено и пулсационно освобождаване и метод за получаването й
CA2302585C (en) Controlled release formulations
AU2001239658A1 (en) Method for producing a controlled-release preparation
NO870558D0 (no) Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat.
CA2351814A1 (en) Taste masked pharmaceutical particles
EP0650353A4 (en) PLEASANT TASTE PHARMACEUTICAL COMPOSITIONS.
PT1207860E (pt) Formulação de peletes de libertação controlada
WO2000021572A3 (en) Hydrogels and water soluble polymeric carriers for drug delivery
WO2001034119A3 (en) Inhibitors of crystallization in a solid dispersion
WO2004091528A3 (en) Delivery systems of homogeneous thermoreversible alginate films
NO20013336L (no) Farmasöytiske preparater
AU2256495A (en) Sustained-release matrix pellets and method for preparing them
CY1107695T1 (el) Μεθοδος παραγωγης επικαλυμμενων δισκιων με συγκαλυμμενη γευση και αμεση απελευθερωση του δραστικου παραγοντα
CA2352211A1 (en) Sustained release matrix systems for highly soluble drugs
WO2002058672A3 (en) Microparticles of biodegradable polymer encapsulating a biologically active substance
EP0616802A4 (en) PREPARATION ORALLY ADMINISTERED TO BE RELEASED IN THE LOWER DIGESTIVE TUBE.
DK1417960T3 (da) Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf
WO2001034118A3 (en) Solid dispersion pharmaceutical formulations
WO2006006691A3 (en) Solid dispersion of a p38 map kinase inhibitor
BG104757A (bg) Пелети, притежаващи сърцевина, обвити с агент, понижаващ липидите и полимер